Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Subcutaneous Injection of Exendin (9-39) in Subjects With Hyperinsulinemic Hypoglycemia Post-Bariatric Surgery

NCT02996812 is registered in ClinicalTrials.gov with Tracey McLaughlin as lead sponsor.

NCT NCT02996812
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996812 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Subcutaneous Injection of Exendin (9-39) in Subjects With Hyperinsulinemic Hypoglycemia Post-Bariatric Surgery
Lead sponsor
Tracey McLaughlin
Phase
Phase 1
Overall status
Completed
Start date
April 30, 2015
Completion date
August 31, 2016
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperinsulinemia hypoglycemia